Source:http://linkedlifedata.com/resource/pubmed/id/17126824
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2006-12-18
|
pubmed:abstractText |
Arteriosclerosis obliterans (ASO) is a serious complication in patients with end-stage renal disease (ESRD) caused by diabetic nephropathy. Adsorption of low-density lipoprotein (LDL) has been performed to treat ASO. While efficacy of this treatment has been reported in limb ischemia, the mechanism underlying the benefit remains unclear. We investigated how LDL adsorption affected soluble adhesion molecules; P-selectin, an endothelial and platelet activation marker; inflammatory cytokines such as interleukin (IL)-1beta, IL-6 and tissue necrosis factor (TNF)-alpha; and lipids in serum.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1,
http://linkedlifedata.com/resource/pubmed/chemical/P-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Cell Adhesion Molecule-1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-8981
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
377
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
198-200
|
pubmed:meshHeading |
pubmed-meshheading:17126824-Aged,
pubmed-meshheading:17126824-Arteriosclerosis Obliterans,
pubmed-meshheading:17126824-Cholesterol, LDL,
pubmed-meshheading:17126824-Diabetes Mellitus,
pubmed-meshheading:17126824-Female,
pubmed-meshheading:17126824-Humans,
pubmed-meshheading:17126824-Intercellular Adhesion Molecule-1,
pubmed-meshheading:17126824-Male,
pubmed-meshheading:17126824-P-Selectin,
pubmed-meshheading:17126824-Renal Dialysis,
pubmed-meshheading:17126824-Vascular Cell Adhesion Molecule-1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
|
pubmed:affiliation |
Department of Internal Medicine (Divisions of Neurology, Nephrology, and Rheumatology) Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. utsumi@nms.ac.jp
|
pubmed:publicationType |
Journal Article
|